Clinical Trial: Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies

Brief Summary: The purpose of this study is to determine whether radioactive iodine, as compared to anti-thyroid medications, is a risk factor for the development or progression of thyroid-associated ophthalmopathy in patients with hyperthyroidism due to Graves' disease. The other aim of this study is to determine the incidence of the various ophthalmopathy subtypes and the utility of orbital antibodies in the diagnosis, classification and monitoring of patients with thyroid-associated ophthalmopathy.

Detailed Summary:
Sponsor: Barwon Health

Current Primary Outcome: Onset or progression of ophthalmopathy following radio-active iodine therapy

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Barwon Health

Dates:
Date Received: February 1, 2007
Date Started: August 2003
Date Completion: January 2006
Last Updated: February 1, 2007
Last Verified: August 2003